Embryonic cardiac chamber maturation: Trabeculation, conduction, and cardiomyocyte proliferation: AMERICAN JOURNAL OF MEDICAL GENETICS PART C (SEMINARS IN MEDICAL GENETICS) by Samsa, Leigh Ann et al.
Embryonic Cardiac Chamber Maturation: Trabeculation,
Conduction and Cardiomyocyte Proliferation
Leigh Ann Samsa1,3, Betsy Yang2,3, and Jiandong Liu2,3
1Department of Cell Biology and Physiology, University of North Carolina, Chapel Hill, NC 27599,
USA
2Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC
27599, USA
3McAllister Heart Institute, University of North Carolina, Chapel Hill, NC 27599, USA
Abstract
Congenital heart diseases are one of the most common human birth defects. Though some
congenital heart defects can be surgically corrected, treatment options for other congenital heart
diseases are very limited. In many congenital heart diseases, genetic defects lead to impaired
embryonic heart development or growth. One of the key development processes in cardiac
development is chamber maturation, and alterations in this maturation process can manifest as a
variety of congenital defects including noncompaction, systolic dysfunction, diastolic dysfunction,
and arrhythmia. During development, to meet the increasing metabolic demands of the developing
embryo, the myocardial wall undergoes extensive remodeling characterized by the formation of
muscular luminal protrusions called cardiac trabeculae, increased cardiomyocyte mass, and
development of the ventricular conduction system. Though the basic morphological and
cytological changes involved in early heart development are clear, much remains unknown about
the complex biomolecular mechanisms governing chamber maturation. In this review, we
highlight evidence suggesting that a wide variety of basic signaling pathways and biomechanical
forces are involved in cardiac wall maturation.
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Introduction
Cardiovascular malformation is one of the leading causes of human birth defects [Parker et
al., 2010], and cardiovascular diseases are the number one cause of adult morbidity and
mortality in the developed world [Go et al., 2013]. During development, in order to increase
cardiac output, the vertebrate embryonic heart undergoes a series of complex morphogenic
processes known collectively as cardiac chamber maturation. Alterations in these processes
are linked to many cardiac diseases such as noncompaction cardiomyopathy (also known as
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hypertrabeculation), diastolic dysfunction, and arrhythmias [Teekakirikul et al., 2013]
Monogenic alterations that lead to human congenital heart defects have been valuable in
identifying key regulators of heart development [Teekakirikul et al., 2013]. Yet, these rare
mutations do not explain the heterogeneity in cardiovascular defects observed clinically in
both children and adults. Clearly, genetic mutations that completely impair heart
development do not appear clinically. Advancements in our understanding of the
mechanisms that govern cardiac chamber maturation and patient-specific genetic
information are necessary for developing improved and personalized therapeutics for these
congenital defects. In this review, we present evidence that collectively suggest a wide range
of signaling pathways are involved in orchestrating cardiac chamber maturation.
Left Ventricular Non-Compaction
One of the most widely recognized disorders of cardiac maturation is left ventricular non-
compaction (LVNC) [Jenni et al., 2007]. LVNC is characterized by prominent trabeculae
and large recesses/sinuses between trabeculae, [Jenni et al., 2001, Stöllberger and Finsterer,
2004]. Patients with LVNC may be symptomatic or asymptomatic, and LVNC leads to heart
failure, thromboembolic events, arrhythmias and/or sudden cardiac death [Bhatia et al.,
2011, Paterick and Tajik, 2012, Ichida et al., 1999]. LVNC can occur as an isolated disease
(called isolated left ventricular noncompaction or ILVNC) or in conjunction with other
congenital defects [Peters 2012, and Stanton, 2009], suggesting multiple etiologies for
LVNC. Due in large part to variable diagnostic criteria [Paterick and Tajik, 2012,
Thavendiranathan et al., 2012], the true burden of LVNC is unknown, but is estimated to be
0.014%–1.3% of children referred to echocardiography laboratories [Oechslin et al., 2000].
The morphology of LVNC hearts closely resembles early embryonic hearts. Because of this
resemblance, frequent comorbidity with other congenital cardiac malformations, and
prevalence in infants, LVNC is widely considered to be caused by the embryonic arrest of
cardiac wall maturation [Angelini et al., 1999, Chin et al., 1990, Sedmera and Thompson,
2000]. However, this hypothesis has been challenged recently [Ichida et al., 1999] given the
identification of LVNC in adults [Oechslin et al., 2000, Murphy 2005, Stöllberger and
Finsterer, 2004] and observation that some of the morphological features of LVNC are
distinct from the embryonic heart [Wessels and Sedmera, 2003, Stanton et al., 2009].
Nevertheless, whether LVNC is strictly congenital, acquired, or both, there is a clear genetic
component to LVNC [Teekakirikul et al., 2013, Oechlin and Jenni, 2011]. Indeed, the
American Heart Association classifies LVNC as a genetic cardiomyopathy [Maron et al.,
2006]. LVNC is associated with mutations in sarcomere-encoding genes, calcium handling
genes, genes that encode proteins of the dystrophin-associated glycoprotein complex
(DTNA), nuclear lamina, Nkx2.5 and with mutations that cause compromised mitochondrial
function [reviewed in Teekakirikul et al., 2013]. Although the genetic studies of LVNC and
other trabecular disorders have identified some genes associated with LVNC, we know little
about how mutations in these genes lead to altered cardiac morphogenesis.
Basic Research in Cardiac Chamber Maturation Biology
Over the past 2 decades, though we have seen substantial progress in our understanding of
the formation of the cardiovascular system, improvements in this understanding are
necessary to develop therapies for non-compaction/trabecular diseases. Much of our
understanding of cardiac ontology is derived from study of human, mouse, and chicken
embryos. However, direct observation of heart development is limited in these organisms.
The zebrafish (Dano rerio) has recently emerged as a powerful vertebrate model organism
for studying early heart development [Beis and Stainier, 2006, Liu and Stainier, 2012]. The
zebrafish heart is simpler than that of higher vertebrates, but recapitulates early cardiac
development. Moreover, accumulating evidence suggests that genes responsible for essential
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steps of cardiovascular development and morphogenesis are conserved throughout
vertebrates [Moorman and Christoffels, 2003]. Unlike the mouse or chicken, the zebrafish
embryo develops entirely externally, and the transparency of the embryos enables direct,
noninvasive observation of heart development at a cellular resolution. External development
also makes it highly accessible for forward genetic approaches and for screening drug
targets. Zebrafish embryos are particularly useful for studying developmental cardiac defects
because they do not initially require a functioning cardiovascular system. Since their early
oxygen needs can be met by passive diffusion, phenotypes that are lethal in other model
systems can be studied in greater detail in zebrafish. In addition, technologies for creating
zebrafish knockout, transgenic, and reporter lines are readily available.
EMBRYONIC CARDIAC CHAMBER MATURATION
During development, in order to increase cardiac output, the vertebrate embryonic heart
undergoes a series of complex morphogenic changes known collectively as cardiac chamber
maturation. The early embryonic heart is a smooth, two-layered linear heart tube composed
of a luminal endocardial endothelial layer and an immature myocardial layer (Fig 1A). This
tube later undergoes extensive growth and topological remodeling to generate the mature
vertebrate heart. Though the ultimate cardiac wall topology is somewhat different between
cardiac chambers and between species, the patterning and processes of wall maturation is
well conserved [Sedmera et al., 2000]. Alterations in these processes are linked to many
cardiac diseases such as non-compaction cardiomyopathy, diastolic dysfunction, and
arrhythmias. A basic understanding of these processes is necessary to appreciate the
morphological defects observed in non-compaction and trabecular disease and to identify
how mutations in genes regulating these processes can lead to non-compaction phenotypes.
Cardiac chamber maturation can be separated into three interrelated processes—formation
of myocardial projections called trabeculae, establishment of the conduction system, and
thickening of the compact myocardium. Each of these processes has been well described
historically, and our description reflects the published current views of leaders in the field.
In the following sections, we will briefly describe the anatomical changes in the cardiac
chamber associated these processes. In the sections following these descriptions, we will
then discuss known regulators of chamber maturation and propose future directions for
research in chamber maturation.
Trabeculation
We direct interested readers to the reviews by and references in Sedmera et al., [2000] and
Moorman and Christoffels [2003] for in depth presentation of the morphological changes
associated with trabeculation. Cardiac trabeculation begins after the cardiac looping stage to
form a network of luminal projections called trabeculae which consist of myocardial cells
covered by the endocardial layer. Trabeculae increase cardiac output and permit nutrition
and oxygen uptake in the embryonic myocardium prior to coronary vascularization without
increasing heart size [Liu et al., 2010, Minot, 1901, Rychter and Ostadal,1971]. As the
cardiac wall matures, the trabeculae undergo extensive remodeling concomitant with
compact myocardial proliferation, formation of the coronary vasculature and maturation of
the conduction system. In humans, infants born with either hypotrabeculated or
hypertrabeculated ventricles have impaired function [Weiford et al., 2004 and Breckenridge
et al., 2007]. The anatomical changes associated with trabeculation can be divided into three
distinct steps—emergence, trabeculation, and remodeling.
Emergence—In the human at Carnegie stage 12, chicken at stage 16/16, mouse at E9.5
and zebrafish around 60 hpf (hour post fertilization), myocardial protrusions begin to appear
extending into the lumen [Sedmara et al., 2000, Moorman and Christoffels, 2003,
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Peshkovsky et al., 2011] (Figure 1B). Recent work using zebrafish embryos have described
this process in greater detail [Peshkovsky et al., 2011]. Trabeculae begin to develop in the
outer curvature of the ventricle in a stereotypical manner starting on the outer curvature
ventrally across from the AV nodes. It is not clear whether these protrusions form by
buckling of the myocardial wall, active invagination of cardiomyocytes into the lumen,
active evagination of the endocardium into the myocardial layer, or some combination of
these actions [Icardo and Fernandez-Teran, 1987, Marchionni 1995, Sedmera and Thomas,
1996] though Peshkovsky et al.’s work would suggest active invagination of the
myocardium as the primary mechanism. In support of this idea, Liu et al. demonstrated that
cardiac trabeculation is primarily driven by delamination of the cardiomyocytes from the
compact myocardium [Liu et al., 2010].
Trabeculation—After the initial trabecular ridges form, trabecular projections propagate
radially to form a network of trabeculae and also increase in length [Peshkovsky et al., 2011;
Sedmera et al, 2000]. During this stage, the majority of the myocyte mass is contained
within trabeculae rather than within the compact wall (Fig 1C). Cells along the longitudinal
axis of each trabecula are more differentiated at the luminal side and less differentiated at
the mural side [Sedmera and Thompson, 2011]. Defects at this stage manifest as either over
or under trabeculated myocardial walls populated by thin trabeculae, and this stage is
considered complete when the first signs of trabecular remodeling begin.
Remodeling—The final stage of trabecular growth is a period of remodeling also known
as consolidation or compaction (independent of expansion of the compact myocardial layer
discussed below). Species and cardiac chamber-specific differences in adult trabecular
morphology are generally attributed to differences in remodeling. This stage is characterized
by trabeculae ceasing growth in the luminal direction and thickening radially (Fig 1D). The
bases of the trabeculae thicken and/or collapse to the point that they are indistinguishable
from the myocardial wall proper. As the trabeculae compact, the spaces between trabeculae
are transformed into capillaries. This compaction stage is considered complete when a
“mature” trabeculated network is evident at Carnegie stage 22, chicken stage 34, and mouse
at E14.5 [Sedmera et al., 2000]. Defects at this stage manifest as overly long, thin trabecular
projections that are separated by deep invaginations in the wall.
Compact Myocardium Proliferation
Though consolidation and compaction of trabeculae increases myocytes mass, the compact
myocardium ultimately provides most of the myocardial mass in the mature heart (Fig 1D).
We direct interested readers to the reviews by and references in Risebro and Riley [2006]
and Sedmera and Thompson [2011] for review of compact layer cardiomyocyte proliferation
and related formation of coronary circulation. Initially, the linear heart tube is comprised of
the endocardial and myocardial layers. Around the same time as the initiation of
trabeculation, cells of the proepicardial organ migrate to the post-looped heart to form its
outermost layer, the epicardium (Fig 1C). As the endocardium and part of the myocardium
generate trabeculae, the more distal portion of the myocardial layer proliferates slowly.
Interestingly, it is well accepted that these cells are less differentiated than the trabecular
myocardium, and by that reasoning should have a greater proliferative capacity than the
trabecular myocytes. Temporally, around the remodeling/compaction step of trabeculation
(above), the epicardium invades the myocardial wall, forming the coronary vasculature and
contributing cardiac fibroblasts to the myocardial wall. The appearance of coronary
vasculature is accompanied by rapid proliferation of the compact layer.
As the compact layer grows in size and complexity, it supplants trabeculae myocardium as
the major contractile force [Wessels and Sedmera, 2003]. This proliferation is concomitant
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with trabecular remodeling, so it is often difficult to distinguish whether altered myocardial
wall structure is from maladaptive trabecular compaction or compact myocardium
proliferation. Factors modulating the spatial and temporal growth of the compact layer are
reviewed in Sedmera and Thompson [2011] and include FGFs, Wnts, RA, and
erythropoietin [Merki et al., 2005, Pennisi 2003, Chen et al., 2002, and Stuckmann et al.,
2003]. Further growth and rearrangement of the compact myocardium occur in post-natal
development.
Conduction System
Non-compaction and trabecular diseases are often associated with arrhythmias, suggesting a
role for altered cardiac action potential conduction in these disorders [Ichida et al., 1999].
Morphological development of the cardiac conduction system and the gene networks
involved have been recently reviewed by Munshi et al [2012], Miquerol et al. [2011], and
Christoffels and Moorman [2009]. In the normal adult vertebrate heart, the cardiac action
potential (AP) is initiated in the atrial sinoatrial node then spreads through the atria, inducing
atrial contraction. The AP is delayed in the atrioventriclar node which allows for completion
of atrial contraction before initiation of ventricular contraction. The AP then travels through
the atrioventriclar bundle and bundle branches and ultimately terminates in the Purkinje
fibers of the arborized peripheral ventricular conduction system (PVCS). The PVCS, also
called the His-Purkinje network, is responsible for depolarizing ventricular cardiomyocytes
in a rapid, coordinated fashion. Clearly, the proper development of the cardiac conduction
system is very complex and involves coordinated growth and differentiation processes. Due
to its physical proximity within the cardiac wall and early embryonic function, the Purkinje
fiber network/PVSC is directly impacted by altered wall maturation observed in
noncompaction and trabecular diseases. Thus, we will restrict our discussion of the
conduction system to the anatomical development of the Purkinje fiber network (PFN) in
this section and the signaling networks involved in a later section.
The mature PVCS consist of Purkinje fibers (PFs) of myogenic origin, insulating fibers, and
nervous input and is located within trabeculae in the subendocardial space between the
endocardial cells and underlying differentiated cardiomyocytes. PFs do not require the
insulating fibers and or external innervation as they can propagate the cardiac AP when
trabeculae have just been formed [Christoffs and Moorman, 2009]. The morphological
appearance of the PFs varies somewhat across vertebrates, but are generally characterized by
underdeveloped sarcomeres, sarcoplasmic reticulum, and mitochondrial network; insulation
by connective tissue (mature fibers only); and connected as an electrically excitable network
detectable by retrograde tracing [reviewed in Munshi, 2012]. Based on lineage tracing data
using different markers in different species, conduction cells are derived from cardiac
progenitor cells and not from endocardial or epicardial cells [reviewed in Miquerol et al.,
2011]. There is some debate as to whether conduction cells arise from direct progenitor
differentiation into conduction cells, from cardiomyocyte differentiation into conduction
cells, or if both derivations are possible [reviewed in Munshi, 2012]. Christoffels and
Moorman [2009] have suggested a model of PF development in which differentiation of
cardiomyocytes on the epicardial side of trabeculae into working cardiomyocytes is opposed
by differentiation of cardiomyocytes on the endocardial side into working PF cells.
SIGNALING PATHWAYS IN CARDIAC CHAMBER MATURATION
Vertebrate small animal models including mouse, chicken and zebrafish have been used to
study the basic cell signaling involved in cardiac wall maturation. Much of what we do
know is from reverse genetic loss of function approaches in which removal of a gene results
in a cardiac chamber maturation phenotype. While gene networks governing general cell
survival and proliferation are essential for cardiac development, at the molecular level,
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cardiac maturation requires specific signaling networks including Notch, Neuregulin,
Ephrin, BMP, FGF, Semaphorin, Retinoic acid, Endothelin, and extracellular matrix
signaling (ECM). As of yet, no comprehensive model has emerged describing the specific
molecular regulators of chamber maturation. In the following section, we will review the
evidence implicating each of these pathways in wall maturation.
Notch
The Notch signaling pathway plays multiple roles during vertebrate cardiac differentiation
and development, including regulation of valve formation, outflow tract development and
cardiac chamber maturation. Upon binding of DELTA or JAGGED family ligands, the
extracellular portion of NOTCH is cleaved by ADAM17 (ADAM metallopetidase domain
17) and the intracellular portion is cleaved by a γ-secretase. This releases the NOTCH
intracellular domain (NICD) into the cytoplasm there it translocates into the nucleus and
associates with transcription factors to activate downstream target genes [MacGrogan et al.,
2010] (Fig 2A). Notch activation is upstream of Ephrin and Neuregulin-based modulation of
trabeculation and BMP10 modulation of cardiomyocyte proliferation (Fig 2A).
Consistent with the involvement of Notch signaling in multiple aspects of cardiac
development, components of the Notch pathway show dynamic spatial and temporal
expression patterns in the developing vertebrate heart and both endocardial and myocardial
expression have been described [reviewed by MacGrogan et al., 2010]. The endocardium
expresses DELTA4, NOTCH1, and NOTCH4 [Krebs et al., 2000, Del Amo et al., 1992,
Uyttendaele et al., 1996] while the myocardium expresses JAGGED1 and NOTCH2
[Loomes 1999, McCright et al., 2002]. NOTCH1 is expressed in the endocardium and its
activated form shows strongest expression at the base of the ventricular trabeculae. In
addition, Notch1 or RBPjk (effector transcription factor) deficient mice display deficient
cardiac wall maturation including failure of cardiac trabeculation, reduced marker genes
expression, and decreased cardiomyocyte proliferation [Grego-Bessa et al., 2007]. The
myocardially expressed NOTCH2 2 has also been shown to play a role in chamber
maturation. NOTCH2 is down-regulated in the compact myocardium layer during mouse
cardiac development. Overexpression of Notch2 in the myocardium leads to
hypertrabeculation, reduced compaction, and septal defects [Yang et al., 2012]. Double
knockout of Numb and Numblike (suppressors of NOTCH2) leads to a comparable
phenotype as NOTCH2 overexpression and increases BMP10 expression which modulates
trabeculation (discussed below) [Yang et al., 2012].
Neuregulin/ErbB
Neuregulin-1 (NRG1) is a Type 1 transmembrane protein and a member of the epidermal
growth factor (EGF) family of ligands. It is highly expressed in the cardiovascular system
and has been implicated in heart development and disease [Odiete et al., 2012].
Transmembrane NRG1 acts as a paracrine ligand. In the heart, binding of NRG-1 to the
ERBB family receptor ERBB4 promotes formation of ERBB4/ERBB2 heterodimeric
signaling complex. ERBB2 tyrosine kinase activity phosphorylates the C-terminal domains,
leading to downstream signaling modulation of gene expression through (Fig 2A)[Yarden
and Sliwkowski, 2001].
In the heart, endocardial derived Neuregulin signaling through ERBB2/4 heterodimers in the
myocardium is essential for proper chamber maturation [reviewed in Fuller et al., 2008].
Mice lacking NRG1 [Meyer 1995] or functional NRG1 Ig-like domain 1 [Kramer et al.,
1996], die before birth due to defective cardiac trabeculation. Likewise, mice lacking either
ERBB2 [Lee et al., 1995] or ErbB4 [Gassmann et al. 1995] also die in early gestation due to
defective trabeculation. Similar to mice, zebrafish devoid of functional ERBB2 protein [Liu
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2010] or with ERBB activity pharmacologically inhibited [Peshkovsky et al., 2011] do not
form trabeculae [Liu et al., 2010]. Detailed lineage tracing and transplantation studies in
zebrafish embryo has suggested that initiation of trabeculation is driven by directional
migration of cardiomyocytes regulated by ERBB2 signaling [Liu et al., 2010].
Since NRG1, ERBB2, and ERBB4 deficiency results in embryonic lethality in multiple
model organisms, it is unlikely that complete loss-of-function mutations are present in the
human populace with congenital heart malformations. However, it is possible that partial
loss of function in these genes or in the up or downstream mediators of Neureglin signaling
could manifest within the cardiac wall malformation disease etiology.
EphrinB2/B4
Ephrin signaling is essential for normal endothelial cell function and thus heart
development. In the heart, Ephrin-B2 (EFNB2) and one of its receptors, EPHB4, are
expressed in the endothelial cells lining trabeculae [Wang et al., 1998]. Eph4 tyrosine kinase
activity leads to downstream signaling that modulates cell shape, migration, and adhesion
[Salvucci and Tosato, 2012] (Fig 2A). In mice, trabeculae fail to form in the absence of
EFNB2 [Wang et al., 1998] or EPHB4 [Gerety et al., 1999].
BMP
Bone morphogenic protein-10 (BMP10) signaling plays an important role in modulating
heart development [Lowery et al., 2010]. BMP10 expression is restricted to cardiomyocytes
in the developing and post-natal heart [Neuhaus et al., 1999]. BMP10 is part of the TGF-β
superfamily of ligands with specificity for ALK1, ALK6, and BMPR2 receptors. Ligand-
receptor binding initiates SMAD signal transduction to modulate gene transcription [Lowery
et al., 2010] (Fig 2A). Global deletion of BMP10 is embryonic lethal with severely reduced
cardiomyocyte proliferative capacity [Chen et al., 2004]. BMP10 appears to modulate
cardiomyocyte differentiation through activation of transcription factors Nkx2.5, Mef2c
[Chen et al., 2004], and Tbx20 [Zhang et al., 2011].
FGF
Fibroblast growth factor (FGF) family of secreted ligands binds to fibroblast growth factor
receptors (FGFR) in either a cell autonomous or non-cell autonomous manner, leading to
complex, cell and context-specific intracellular signaling (Fig 2A). Proliferation of the
compact myocardium requires FGF signaling [Mikawa 1995, Mima et al., 1995]. In mouse
embryos, the FGF9 family members FGF9, FGF16, and FGF20 are expressed in both the
endocardium and epicardium and are important regulators of regulate cardiomyocyte
proliferation [Lavine et al., 2005; Lu et al., 2008].
Semaphorins
Semaphorin signaling through Plexin receptors modulate cell behavior and gene
transcription through complex intracellular signaling cascades [Zhou et al., 2008] (Fig 2B).
Though Semaphorins are more typically known for their role in axonal migration, members
of the semaphorin family, such as SEMA6D (Semaphorin-6D) have been shown to play a
role cardiac patterning, and SEMA6D loss-of-function leads to trabeculation phenotypes
[Toyofuku et al., 2004a, b]. In mouse and chicken embryos, knockdown of SEMA6D or its
receptor PLXNA1 (PlexinA1) in mouse and chicken embryos leads to the typical
noncompaction phenotype with a thin compact myocardium and expansive spongy
trabeculated myocardium [Toyofuku et al., 2004a, b].
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Retinoic acid (RA) is derived from Vitamin A. Both Vitamin A deficiency [Wilson and
Warkany, 1949; Wilson et al., 1953] and exposure of embryos to excess Vitamin A leads to
cardiac defects [Morriss-Kay, 1992]. Canonically, lipophilic RA diffuses into cells and
binds to the retinoic acid receptor RXRs on the nuclear membrane (Fig 2B). RXRs directly
bind DNA to regulate gene transcription [Duester, 2008]. Genetic ablation of the retinoic
acid receptor RXRα is embryonic lethal in mice due to failed proliferation of the compact
myocardium [Sucov et al., 1994]. This arrest of cardiomyocyte proliferation is not directly
attributable to RA signaling on cardiomyocytes. Rather, RA appears to induce the
epicardium to secrete trophic factor(s) that mediate cardiomyocyte proliferation [Chen et al.,
2002, Stuckmann et al., 2003].
Endothelin
In the developing heart, cardiomyocyte differentiation into Purkinje fibers is regulated in
part by endothelin signaling [Takebayashi-Suzuki, 2000]. Pro-endothelin (Pro-ET), the
precursor of active endothelin-1 (ET1), is produced by endothelial cells in response to shear
stress (the force of fluid flow parallel to the endocardial surface). Presumably due to higher
levels of shear stress, in the heart endocardial and arterial endothelial cells, but not venous
endothelial cells or cardiomyocytes, produce the endothelin-converting enzyme-1 (ECE1)
necessary to convert Pro-ET into ET1. ET1 interacts with the G-protein coupled receptor
EDNRA (endothelin receptor type A) to induce cardiomyocytes to differentiate into Purkinje
fibers [Gourdie et al., 1998, Takebayashi-Suzuki, 2000] (Fig 2B). ECE1 is required for
normal Purkinje fiber formation [Hall et al., 2004].
Extracellular Matrix Molecule Signaling
Each of the cardiac layers—endocardial, myocardial, and epicardial—are separated by
layers of extracellular matrix (ECM). ECM-cell interactions are coupled cell signaling
though transmembrane proteins called integrins which, upon binding undergon
conformational changes that lead to complex cell and context-depending cell signaling (Fig
2B). Integrins modulate intracellular signaling cascades to modulate many cellular processes
including growth, migration, survival, and differentiation. Integrins exist as heterodimers,
and ligand specificity is conferred by different combinations α and β subunit isoforms. The
α4 integrin is essential for cell adhesion during cardiac development [Yang et al., 1995].
The exact composition of cardiac ECM is important for normal cardiac development.
Though there are many ECM proteins present in the developing heart, collagen [Tahkola et
al., 2008], versician [Cooley et al., 2012] and nephronectin [Patra et al., 2011] have emerged
as important ECM components. During cardiac morphogenesis, the ECM is broken down by
matrix metalloproteases to facilitate cell migration. ECM composition is regulated at least in
part by the matrix metalloprotease ADAMTS1, which is necessary for trabeculation
[Stankunas et al., 2008].
BIOMECHANICAL FORCES IN CARDIAC WALL MATURATION
Though genes regulating cell signaling are clearly essential for cardiac chamber maturation,
epigenetic factors such as the biomechanical forces influence heart development. We direct
interested readers to a recent review by Granados-Riveron and Brook [2012] for an analysis
of mechanical forces in heart development [Granados-Riveron and Brook, 2012]. During
development, the heart is exposed to many biomechanical forces including those exerted on
the wall by blood flow (shear stress), by fluid pressure (cyclic strain), within the wall by
cell-cell attachments, and on the wall by extracardiac pressures (Fig 3). In general, the
signaling mechanisms through which cells translate biomechanical forces into changes in the
signaling events that modulate cardiac wall patterning are poorly understood.
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Fluid flow plays an important role in trabeculation, cardiomyocyte proliferation, and
establishment of the cardiac conduction system. While flow exerts a force parallel to the
vessel wall called shear stress, fluid pressure exerts force on the developing heart to the
vessel wall. This pressure, also known as mechanical load, can be manipulated ex vivo in
developing hearts. Reduced mechanical load is mimicked by maintaining hearts in normal
atmospheric pressure, while increased mechanical load is mimicked by filling the ventricles
to end diastolic volume by injection of silicon oils. In chick, changing the mechanical load
leads to altered development of the conduction system, impaired growth, and disorganized
trabeculae [Sankova et al., 2010].
Likewise, zebrafish carrying an atrial sarcomere mutation, the Wea mutant, have weak blood
flow in the ventricles [Berdougo et al., 2003]. Wea mutants exhibit reduced trabeculation
[Peshkovsky et al., 2011>]. One way that cells sense flow is through the bending of primary
cilia. Primary cilia are sensory organelles that protrude from the normal plane of the cell
membrane and are found on nearly every cell type, including endothelial cells. Interestingly,
mice that do not have primary cilia have decreased cardiac trabeculation and abnormal
outflow tract development [Clement et al., 2009], suggesting a role for shear stress sensing
in chamber maturation.
Stretch
During the cardiac cycle, individual cardiomyocytes are subjected to stretch. When
stretched, endothelial cells produce Pro-ET which is converted by ECE1 into ET1, and ET1
signaling is essential for Purkinje fiber differentiation [Takebayash-Suzuki, 2000]
Pharmacological inhibition of stretch responsive channels leads to decreased expression of
ECE1 in the endocardium and decreased expression of the Purkinje fiber specific marker
connexin40 in the developing chick ventricle [Hall et al., 2004]. Conversely, pressure
overload by truncal banding increases Purkinje fiber formation [Hall et al., 2004]. Thus,
mechanical forces play a role in Purkinje fiber development at least in part through
modulation of ET1 signaling.
Inward forces
The developing heart in its entirety is contained within the splanchnopleural cavity.
Advances in four-dimensional optical coherence tomography (OCT) have permitted study of
the complex interrelationship between cardiac layers during the cardiac cycle. Garita et al.
[2009] used OCT imaging in chick and mouse embryos to demonstrate that the
splanchnopleural membrane interacts with the myocardial wall. This study is the first to
demonstrate a direction interaction of the developing heart interacts with its boundaries,
suggesting that inward transduction of this mechanical interaction could play a role in final
positioning of the heart.
NEW AREAS FOR INVESTIGATION
Though a few genes have been implicated as necessary for trabeculation, much work
remains to fully characterize cardiac trabeculation. Greater understanding of the normal
morphogenesis of the heart will inform treatment efforts and could play a role in developing
personalized therapeutics.
The first question which remains to be addressed is how the spatial pattern of cardiac
trabeculation is generated. NRG-1 and its receptors appear to be expressed uniformly in the
ventricular endocardium and myocardium respectively; however, it is not clear whether
Neuregulin/ErbB signaling is spatially activated to select certain cardiomyocytes to initiate
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cardiac trabeculation. Alternatively the spatial regulation of cardiac trabecular initiation can
be achieved by the interplay of multiple signaling pathways, such as the Neuregulin/ErbB
and Semaphorin/Plexin pathways. In addition, the initiation of cardiac trabeculation appears
to be driven by cardiomyocytes delamination, but little is known about the cellular basis of
cardiomyocyte delamination. It is also conceivable that once certain cardiomyocytes are
selected to initiate cardiac trabeculation, they might inhibit their neighbors from adopting a
trabecular cardiomyocyte fate. It will be interesting to determine whether and how such
lateral inhibition mechanism is employed to maintain the homeostasis of the compact
myocardium. Mechanical force also plays an important role in trabeculation. Cardiac
trabeculation is significantly reduced in zebrafish wea mutant embryos with reduced blood
flow in the ventricle. Likewise, in human, mutations in sarcomere –encoding genes can
cause trabecular non-compaction in the left ventricles, suggesting in humans mechanical
force associated with cardiac contraction can also have an effect on embryonic heart
development as well. Thus, it will be important to study how the heart senses and responds
to mechanical force to regulate cardiac chamber maturation.
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Figure 1. Cardiac chamber maturation
Figure 1A–D features a schematized cross-section of a theoretical ventricle wall with the
developing atrio-ventricular canal represented as the open break in the ventricle wall, such
that the outer curvature is on the left and the inner curvature is on the right. (A) Early in
development, the cardiac chamber wall is smooth and consists of endocardial cells and
myocardial cells. (B) Emergence: Myocardial protrusions called trabeculae begin to appear
in the outer curvature of the ventricle, projecting into to the lumen. The trabeculae are lined
by a continuous layer of endocardium. (C) Trabeculation: Trabeculae increase in length and
the chamber wall becomes topologically more complex as additional trabeculae form
throughout the outer curvature, creating a meshwork network of interconnected trabeculae.
The compact myocardium does not thicken appreciably. A third layer of cells, the
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epicardium, surrounds the developing heart. (D) Compaction/Remodeling. Trabeculae cease
luminal growth, thicken radially, and their base coalesces to form part of the solid
myocardial wall. The compact myocardium increases in mass concomitant with the coronary
vessel formation in the myocardial wall. The compact myocardium is shown in dark blue,
trabecular cardiomyocytes in cerulean, endocardial cells in green, and epicardial cells in
purple. The developing cardiac vasculature is represented by gray circles outlined in green.
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Figure 2. Signaling pathways in cardiac chamber maturation
Several signaling pathways have been identified as key regulators of cardiac chamber
morphogenesis. Please see below for abbreviations. (A) Canonical NOTCH ligands
including Delta and Jagged family members bind to NOTCH family receptors. Upon
binding, ADAM17 cleaves the extracellular domain of NOTCH and γ-secretase cleaves the
intracellular domain of NOTCH, releasing the NICD into the cytoplasm. NICD translocates
into the nucleus and modulates gene transcription. NOTCH activation leads to stimulation of
EphrinB2 signaling through EPH4 and NRG1 signaling through ERBB2/4, both of which
are essential for trabeculation. NOTCH activation also leads to activation of BMP signaling
through BMP10/BMPR interactions and FGF signaling through FGFR. BMP and FGF
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signaling are essential for cardiomyocyte proliferation and expansion of the compact
myocardium. (B) Other signaling pathways essential for cardiac chamber maturation.
SEMA6D signaling though PLXNA1 activates the enabled homolog MENA, modulating
both trabeculation and compact myocardium proliferation/expansion. Vitamin A is oxidized
into retinoic acid. Retinoic acid family members, RXRs, bind retinoic acid and translocate
into the nucleus where they influence gene transcription involved in compact cardiomyocyte
proliferation. Pro-endothelin secreted into extracellular space is converted into ET-1 by
ECE1. ET-1 binding activates the G-protein coupled receptor EDNRA, leading to
downstream signaling and gene transcription essential for Purkinje Fiber formation. Diverse
extracellular matrix molecules collectively referred to as ECM, either whole or after
proteolysis by MMPs, interact with α/β integrin heterodimers. This induces conformation
changes in the integrin heterodimer that activate downstream signal transduction that
ultimately modulates all elements cardiac chamber maturation. Abbreviations: NRG1;
Neuregulin-1: ERBB2/4; heterodimer with ErbB2 (v-erb-b2 erythroblastic leukemia viral
oncogene homolog 2) and ErbB4 (v-erb-a erythroblastic leukemia viral oncogene homolog
4): EFNB2; Ephrin-B2: EPHB4; EPH receptor B4: ADAM17; ADAM metallopeptidase
domain 17: NOTCH; NOTCH family receptors: γ-secretase; gamma-secretase: NICD;
NOTCH intracellular domain: BMP10; Bone Morphogenic Protein 10: BMPR2; Bone
morphogenic Protein receptor, type II: SMAD; SMAD family transcription factors: FGF;
Fibroblast Growth Factors: FGFR; Fibroblast Growth Factor Receptors: SEMA6D;
Semaphorin 6D: PLXNA1; Plexin A1: MENA; Enabled homolog (mammalian): RXR;
Retinoic Acid Receptor family: Pro-ET; Pro-endothelin: ECE1; Endothelin-converting
enzyme 1: ET-1; Endothelin 1: EDNRA; Endothelin receptor type A: ECM; Extra Cellular
Matrix components: MMP; Matrix Metalloprotease.
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Figure 3. Biomechanical forces in Cardiac Wall Maturation
Biomechanical forces are important for normal developmental patterning. Forces exerted on
the wall from blood flow include (A) cyclic strain, a force perpendicular to the vessel wall,
and (B) shear stress, the frictional force parallel to the vessel wall. (C) Force from cardiac
contraction exerts strain on myocardial and endothelial cell-cell junctions. (D) The
splachnopleural membrane interacts with the myocardial wall during development and may
exert an inward pressure on the myocardial wall.
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